MedPath

to study the effect of Metocloparamide and Dexamethsone drugs in reducing vomiting in patients undergoing laproscopic cholecystectomy

Not Applicable
Conditions
Health Condition 1: null- patients of ASA grade I&II planned for laproscopic cholycestectomypatients age of 18-55yrpatients weight between 30-75kg
Registration Number
CTRI/2012/05/002668
Lead Sponsor
Subharti Medical College Meerut
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

pt. of ASA grade I & II ,

weight between 30 to 75kg

Exclusion Criteria

Pt ASA grade 3 & 4

Pt who have received opoids ,steroids and any antiemetic within 24hr

Pt having contraindication or hypersensivity to metocloparamide

pregnant female

Pt having history of PONV & motion sickness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To evaluate the efficacy of i.v dexamethasone 5mg + metocloparamide 10mg on PONV <br/ ><br>2) To evaluate the efficacy of i.v dexamethasone 2.5mg + metocloparamide 10mg on PONV <br/ ><br>3)To evaluate the efficacy of i.v metocloparamide 10mg on PONVTimepoint: at 0-1hr <br/ ><br>at 1-4 hr <br/ ><br>at 4-8hr <br/ ><br>at 8-12hr <br/ ><br>at 12-24hr
Secondary Outcome Measures
NameTimeMethod
comperative evaluation of these drug on POnVTimepoint: at 0-1hr <br/ ><br>at 1-4 hr <br/ ><br>at 4-8hr <br/ ><br>at 8-12hr
© Copyright 2025. All Rights Reserved by MedPath